Cancer Biology & Medicine

Papers
(The H4-Index of Cancer Biology & Medicine is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Multiplex imaging reveals the architecture of the tumor immune microenvironment133
Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity66
Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era42
Peptide drugs: a new direction in cancer immunotherapy42
The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study39
Hot issues in triple-negative breast cancer37
Drug clinical trials on high-grade gliomas: challenges and hopes34
Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors32
Metabolic regulation of innate immunity in cancer immunotherapy32
Recent advances in the systemic treatment of gastrointestinal stromal tumors24
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy23
The interplay between H3K36 methylation and DNA methylation in cancer20
Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies19
Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells19
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling19
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer19
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives18
DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation18
Evolving molecular subtyping of breast cancer advances precision treatment18
0.1062479019165